Ariadne has appointed World Fusion as its exclusive distributor in Japan, where the latter will serve as a support centre for Ariadne's MedScan and Pathway Studio product lines.
'Our customers have been using Pathway Studio in different fields: RNAi, target and biomarker discovery, disease mechanism research, and many others to organise published information and use it to supplement experimental work and validate hypotheses,' said Kozo Kawahara, president of World Fusion.
'World Fusion has been successfully reselling Ariadne's products to Japanese biotechnology and pharmaceutical companies for more than four years,' said Ilya Mazo, president of Ariadne. 'We expect World Fusion will expand to the academic market and will be successful as exclusive distributor.'
